BM‐MSC vs no treatment
Functional impairment · people with probable or definite amyotrophic lateral sclerosis/motor neuron disease (treated with riluzole)
2 findings from 1 review
- Cell‐based therapies for amyotrophic lateral sclerosis/motor neuron disease 2019 · Cochrane Headline outcomes onlyno estimate extracted1 study · 56 participantsLow
- Cell‐based therapies for amyotrophic lateral sclerosis/motor neuron disease 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found